For people with diabetes, constant management of blood sugar is a part of life, Protomer is developing a glucose responsive insulin that can automatically adjust its activity in the body throughout the day.
We see an achievable future of tight blood-glucose control without constant monitoring, multiple daily injections, or a plethora of external devices. To achieve this vision, we are using our MEPS technology to develop a glucose-responsive insulin that can automatically sense rising sugar levels in the body and activate when needed and turn off when blood sugar levels are reduced back to normal levels.
We are also using the MEPS platform to develop a smart glucagon, a glucagon that can give diabetics the freedom to inject insulin without fear of hypoglycemia.
Protomer’s next-generation insulins are glucose responsive, providing added safety and convenience for millions of diabetics around the world.